lead position
Patents
McDermott Will & Schulte lawyers explore why the UPC is seeing rapid adoption by medtech for fast-moving disputes, while pharma and biotech take a cautious, selective approach over revocation risks
September 29, 2026
Features list
-
Kate Nuehring Su, partner at Marshall, Gerstein & Borun, explores a successful PTAB appeal and why the Federal Circuit reached an opposite outcome on the same doctrine -
Todd Hopfinger, director in Sterne Kessler’s electronics practice group, says IP owners are contemplating how patent rights will be enforced as commercial activity expands beyond Earth
-
From cross-border jurisdiction to the end of the transitional period, Powell Gilbert’s Ioana Sabau and Bryce Matthewson predict the biggest talking points ahead
-
Thomas Lonsdale and Hsu Min Chung of HGF explore the practical impact of the EPO’s Enlarged Board of Appeal’s decision in G1/25 and its interplay with G1/24
-
As AI adoption accelerates across corporate IP departments, Simon Webster, president of IP at Clarivate, argues that success will depend less on technology alone and more on data quality, workflow design, and organisational readiness
-
From seller vetting and proprietary screening technology to brand collaboration and industry partnerships, Temu explains how its intellectual property enforcement programme combats infringement on its marketplace
Local Insights
Sponsored by
INLEX
Igor Charles and Théo Coquis of INLEX explain a courtroom battle over a weaponised ‘Obelix’ mark and how the decision provides guidance on the evidence required to establish a trademark’s reputation
Sponsored by
Inventa
Vítor Palmela Fidalgo of Inventa shares initial takeaways on trademark law, political parody, and freedom of expression after the CJEU’s ruling
Sponsored by
Becerril, Coca & Becerril (BC&B)
Erick Sevilla Carrera of Becerril, Coca & Becerril explains how Mexico’s 2026 regulations clarify the evidence required to prove acquired distinctiveness and secure trademark protection for non-distinctive signs
Sponsored by
HANOL ClassHankyul IP & Law
Min Son of HANOL ClassHankyul IP & Law says the decision highlights the importance of demonstrated technical effects, claim amendments, and post-filing evidence, with potentially significant implications for the OLED industry
Sponsored by
Hechanova Group
Editha R Hechanova of Hechanova Group outlines how the guidelines clarify human creative contribution, disclosure requirements, and the registrability of AI-assisted and AI-enhanced works
Sponsored by
Saint Island International Patent & Law Offices
Recent case law has effectively established a checklist for the Intellectual Property and Commercial Court when assessing inventive step in patent cases, says Sumin Lai of Saint Island International Patent & Law Offices
Sponsored by
IPSILON
Joran Michiels of IPSILON Belgium examines how recent EPO and UPC decisions may support inventive-step arguments for CARs, ADCs, bispecific antibodies, and other next-generation therapeutics
Sponsored by
Tilleke & Gibbins
Khin Myo Myo Aye and Niko Myint Soe of Tilleke & Gibbins explain why evidence of trademark use remains crucial in Myanmar for establishing distinctiveness, well-known status, and stronger enforcement rights
Sponsored by
Tilleke & Gibbins
The National Assembly has moved swiftly after the US Trade Representative designated Vietnam a ‘Priority Foreign Country’, report Linh Duy Mai and Giang Hoang Bach of TGVN, the local associate of Tilleke & Gibbins
Sponsored by
Licks Attorneys
Senior legal practitioners of Licks Attorneys explain how antibody characterisation during prosecution can shape patent scope, validity, and enforcement in Brazil, with lessons from the US Amgen v Sanofi decision